UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adverse Effects of Aldosterone: Beyond Blood Pressure

Journal of the American Heart Association, 2024-04, Vol.13 (7), p.e030142-e030142

Brown, Jenifer M

2024

Volltextzugriff (PDF)

Primary Aldosteronism: State-of-the-Art Review

American journal of hypertension, 2022-12, Vol.35 (12), p.967-988

2022

Volltextzugriff (PDF)

Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure

European heart journal, 2020-07, Vol.41 (25), p.2366-2375

2020

Volltextzugriff (PDF)

Human Interventions to Characterize Novel Relationships Between the Renin–Angiotensin–Aldosterone System and Parathyroid Hormone

Hypertension (Dallas, Tex. 1979), 2014-02, Vol.63 (2), p.273-280

2014

Volltextzugriff (PDF)

Recalibrating Interpretations of Aldosterone Assays Across the Physiologic Range: Immunoassay and Liquid Chromatography–Tandem Mass Spectrometry Measurements Under Multiple Controlled Conditions

Journal of the Endocrine Society, 2022-06, Vol.6 (6), p.bvac049

2022

Volltextzugriff (PDF)

Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function

The journal of clinical endocrinology and metabolism, 2017-04, Vol.102 (4), p.1387-1395

2017

Volltextzugriff (PDF)

Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus

Journal of the American Heart Association, 2021-07, Vol.10 (13), p.e018555-e018555

2021

Volltextzugriff (PDF)

The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study

Annals of internal medicine, 2020-07, Vol.173 (1), p.10-20

2020

Volltextzugriff (PDF)

Coronary Microcirculatory Dysfunction in People With HIV and Its Association With Antiretroviral Therapy

Journal of the American Heart Association, 2023-11, Vol.12 (22), p.e029541

2023

Volltextzugriff (PDF)

Prior SARS-CoV-2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography

Journal of the American Heart Association, 2022-10, Vol.11 (20), p.e025844-e025844

2022

Volltextzugriff (PDF)

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee

Journal of the American College of Cardiology, 2020-09, Vol.76 (9), p.1117

2020

Volltextzugriff (PDF)

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Journal of the American College of Cardiology, 2018-12, Vol.72 (24), p.3200-3223

2018

Volltextzugriff (PDF)

Reassessing the management of hypertension: Time to prevent aldosterone‐mediated heart failure

European journal of heart failure, 2024-02, Vol.26 (2), p.195-198

2024

Volltextzugriff (PDF)

The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study

Annals of internal medicine, 2017-11, Vol.167 (9), p.630

2017

Volltextzugriff (PDF)

Probing the Depths: Subendocardial Ischemia and Clinical Outcomes

JACC. Cardiovascular imaging, 2023-01, Vol.16 (1), p.95-97

2023

Volltextzugriff (PDF)

Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease

European heart journal, 2022-09, Vol.43 (35), p.3323-3331

2022

Volltextzugriff (PDF)

Evaluating the clinical and mechanistic effects of eplerenone and amiloride monotherapy, and combination therapy with cinacalcet, in primary hyperparathyroidism: A placebo‐controlled randomized trial

Clinical endocrinology (Oxford), 2023-04, Vol.98 (4), p.516-526

2023

Volltextzugriff (PDF)

Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion

International Journal of Endocrinology, 2017-01, Vol.2017 (2017), p.1-8

2017

Volltextzugriff (PDF)

Biomarkers to Guide Medical Therapy in Primary Aldosteronism

Endocrine reviews, 2024-01, Vol.45 (1), p.69-94

2024

Volltextzugriff (PDF)

Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys

Annual review of medicine, 2023-01, Vol.74 (1), p.217-230

2023

Volltextzugriff (PDF)

The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension

Annals of internal medicine, 2018-05, Vol.168 (10), p.755

2018

Volltextzugriff (PDF)

Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study

Hypertension (Dallas, Tex. 1979), 2022-09, Vol.79 (9), p.1984-1993

2022

Volltextzugriff (PDF)

Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity

The journal of clinical endocrinology and metabolism, 2017-06, Vol.102 (6), p.1835-1843

2017

Volltextzugriff (PDF)

The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study

The journal of clinical endocrinology and metabolism, 2024-08, Vol.109 (9), p.2220-2232

2024

Volltextzugriff (PDF)

Saline suppression testing-induced hypocalcemia and implications for clinical interpretations

European journal of endocrinology, 2024-08, Vol.191 (2), p.241-250

2024

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(139)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Adverse Effects of Aldosterone: Beyond Blood Pressure

Primary Aldosteronism: State-of-the-Art Review

Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure

Human Interventions to Characterize Novel Relationships Between the Renin–Angiotensin–Aldosterone System and Parathyroid Hormone

Recalibrating Interpretations of Aldosterone Assays Across the Physiologic Range: Immunoassay and Liquid Chromatography–Tandem Mass Spectrometry Measurements Under Multiple Controlled Conditions

Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function

Coronary Microvascular Dysfunction in Systemic Lupus Erythematosus

The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study

Coronary Microcirculatory Dysfunction in People With HIV and Its Association With Antiretroviral Therapy

Prior SARS-CoV-2 Infection Is Associated With Coronary Vasomotor Dysfunction as Assessed by Coronary Flow Reserve From Cardiac Positron Emission Tomography

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Reassessing the management of hypertension: Time to prevent aldosterone‐mediated heart failure

The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study

Probing the Depths: Subendocardial Ischemia and Clinical Outcomes

Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery disease

Evaluating the clinical and mechanistic effects of eplerenone and amiloride monotherapy, and combination therapy with cinacalcet, in primary hyperparathyroidism: A placebo‐controlled randomized trial

Angiotensin-Converting Enzyme Inhibition and Parathyroid Hormone Secretion

Biomarkers to Guide Medical Therapy in Primary Aldosteronism

Primary Aldosteronism and the Role of Mineralocorticoid Receptor Antagonists for the Heart and Kidneys

The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension

Cardiac Structure and Function Across the Spectrum of Aldosteronism: the Atherosclerosis Risk in Communities Study

Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity

The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study

Saline suppression testing-induced hypocalcemia and implications for clinical interpretations

Suchergebnisse filtern